However, limited studies have shown a relationship between PgR expression and tumor immunity in breast cancer; PgR expression is inversely associated with programmed death-ligand 1 (PD-L1) expression in epithelial cells or the stroma and the infiltration of CD8+ T and CD20+ B cells [9, 33, 34]. The gene discussed is CD274; the disease is breast carcinoma.